In this article, we will discuss Olaparib (Patient Selection-1). So, let’s get started.
- Patient Selection for gBRCAm Advanced Ovarian Cancer
- Select patients for the treatment of advanced ovarian cancer with Olaparib based on the presence of deleterious or suspected deleterious BRCA-mutations.